DOCSLIB.ORG

Synergistic Interaction Between L-8-D~Arabinofuranosylcytosine

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Synergistic Interaction Between L-8-D~Arabinofuranosylcytosine Proc. NatL Acad. Sci. USA Vol. 78, No. 8, pp. 5132-5136, August 1981 Medical Sciences Synergistic interaction between l-8-D~arabinofuranosylcytosine, thymidine, and hydroxyurea against human B cells and leukemic blasts in vitro (biochemical modulation/deoxycytidine triphosphate/isobologram analysis) JEROME A. STREIFEL AND STEPHEN B. HOWELL Department of Medicine and The Cancer Center, University of California at San Diego, La Jolla, California 92093 Communicated byJ. Edwin Seegmiller, March 9, 1981 ABSTRACT Isobologram analysis was used to examine the in- hance the phosphorylation ofAra-C in murine cells (12, 30-32) teraction between 1-fiD-arabinofuranosylcytosine (Ara-C), thy- and to markedly improve the therapeutic ratio ofAra-C against midine (dThd), and hydroxyurea. All three pairs ofdrugs, as well the murine L1210 leukemia in vivo (33). as the triple combination, were synergistic against a human B cell We used the technique of isobologram analysis (34) to in- line in vitro across a broad range of concentrations. Synergy was vestigate the interactions between Ara-C, dThd,. and HU associated with an increase in the Ara-C nucleotide pool and Ara- against a human B cell line in vitro and found that all three pairs C triphosphate concentration. dThd increased, and hydroxyurea and the triple combination of the drugs interacted synergisti- decreased, the incorporation ofAra-C into trichloroacetic acid-in- soluble macromolecules per unit time. Hydroxyurea was more cally. On an equimolar basis, HU was more effective than dThd effective than dThd at equimolar concentrations in increasing the in increasing the Ara-C nucleotide pool in both the B cell line acid-soluble Ara-C pool. Maximal stimulation of Ara-C triphos- and in malignant blasts from six patients with acute leukemia. phate formation by dThd occurred at 1 mM and was associated with reduction of the deoxycytidine triphosphate pool to 31% of MATERIALS AND METHODS control. At the same concentration, hydroxyurea increased Ara- C triphosphate formation to a greater extent but increased de- Drugs. dThd was obtained from the Investigative Drug oxycytidine triphosphate to 116% of control. When tested at clin- Branch ofthe National Cancer Institute. Ara-C was purchased ically achievable concentrations on blasts from patients with acute from Upjohn, HU from Sigma, and [3H]Ara-C from New En- leukemia, hydroxyurea increased the Ara-C nucleotide pool in all gland Nuclear. six cases studied, whereas dThd decreased the Ara-C nucleotide Cells. The SB cell is a human B lymphocyte line transformed pool. These results indicate that in SB cells dThd and hydroxyurea by Epstein-Barr virus (35). SB cells in the logarithmic phase work by different mechanisms to augment the Ara-C nucleotide of growth were seeded at 2 x 105 cells per ml in RPMI-1640 pool and that hydroxyurea may be more effective than dThd as medium with 10% heat-inactivated fetal calf serum, 1% anti- a modulator of Ara-C activity in patients with acute leukemia. biotic solution (penicillin at 10,000 units/ml, Fungizone at 25 .ag/ml, and streptomycin at 10,000 /i/ml) (Flow Laboratories, 1-3-D-Arabinofuranosylcytosine (Ara-C) is one of the most im- McLean, VA), and 1% glutamine at 370C in 5% CO2. The final portant drugs in the treatment ofhuman acute leukemia (1-4). concentration of dThd in the medium contributed by the fetal A significant increase in the selectivity ofAra-C may have far- calf serum was 0.5 1LM. In growth assays the number of viable reaching consequences for the management ofthis disease. Ara- cells present after 72 hr was determined by trypan blue dye C behaves as an analog of deoxycytidine (dCyd) that, when exclusion. Leukemic human blasts were recovered from the phosphorylated to 1-,3-D-arabinofuranosylcytosine triphos- marrow or peripheral blood ofpatients with acute leukemia by phate (Ara-CTP), is a potent inhibitor of DNA polymerase Ficoll/Hypaque separation (36) and washed twice before in- (5-7) and is also incorporated into DNA (7-9). The activity of cubation with drugs. Ara-C is determined by the amount ofAra-CTP formed within [3H]Ara-C and [3H]Uridine Incorporation. SB cells (0.2 x the cell, and the concentration of the natural substrate deoxy- 106 cells per ml) and leukemic blasts (0.5-2.0 x 10r cells per cytidine triphosphate (dCTP), with which Ara-CTP must com- ml) were exposed-simultaneously to [3H]Ara-C or [3H]uridine pete for binding to DNA polymerase (5, 6, 10, 11). with either HU or dThd for 4 hr. The acid-soluble fraction of Phosphorylation of Ara-C is normally constrained by feed- [3H]Ara-C and its metabolites was calculated as the difference back inhibition ofdCTP on dCyd kinase, the enzyme catalyzing between the radioactivity in whole cells after washing and the the rate-limiting step in the dCyd salvage pathway (12, 13). radioactivity precipitable with trichloroacetic acid. The fraction Thymidine (dThd) has been shown to increase the toxicity of of [3H]uridine incorporated into RNA was determined by al- Ara-C in vitro and in vivo against several murine (14-17) and kaline hydrolysis of the RNA. human tumors (16). This is in part due to the ability ofthymidine Measurement of [3H]Ara-CTP and dCTP. After a 4-hr ex- triphosphate (dTTP) to inhibit ribonucleotide reductase (18), posure to [3H]Ara-C, cells were extracted with 0.4 M perchloric which catalyzes an obligatory step in the die novo synthesis of acid, clarified by centrifugation, and neutralized with Alamine/ dCTP (19, 20) and depletes the cellular dCTP pool (15, 18, 19, Freon, as described by Khym (37). [3H]Ara-CTP was separated 21-26). Hydroxyurea (HU) is also an inhibitor of mammalian from other Ara-C nucleotides by high-pressure liquid chro- ribonucleotide reductase (27), but one that binds at a different matography usinga Waters instrument (Waters Associates) with site than dTTP (28, 29). HU has also been demonstrated to en- a Partisil-10 SAX solumn (Whatman). Extract from 8 X 105 cells The publication costs ofthis article were defrayed in part by page charge Abbreviations: Ara-C, 1-f3-D-arabinofuranosylcytosine; Ara-CTP, 1-f3- payment. This article must therefore be hereby marked "advertise- D-arabinofuranosylcytosine triphosphate; Ara-U, I-P-D-arabinofura- ment" in accordance with 18 U. S. C. §1734 solely to indicate this fact. nosyluracil; HU, hydroxyurea. 5132 Downloaded by guest on September 27, 2021 Medical Sciences: Streifel and Howell Proc. Natl. Acad. Sci. USA 78 (1981) 5133 was injected onto the column and eluted isocratically at 30'C 3, with 0.4 M ammonium phosphate/acetonitrile (10:1, vol/vol) at a flow rate of 2 ml/min (38). Fractions were collected and 2 A B radioactivity was measured by liquid scintillation counting. dCTP concentration was determined in cell extracts by the Ei method of Garrett and Santi (38). Extract from 50 X 106 cells E- 1 was injected on the high-pressure liquid chromatography col- umn, using the same conditions as for the measurement ofAra- CTP. Column output was monitored by absorbance at 280 nm 0 50 100 150 200 0 50 100 150 200 and the peak areas were electronically integrated. External Ara-C, nM Ara-C, nM standards of dCTP were used for calibration. FIG. 2. Isobolograms depicting the interaction between Ara-C and dThd (A), and Ara-C and HU (B) at concentrations that kill 90% of the RESULTS SB cells (cytotoxic). See Fig. 1 for explanation. Isobologram Analysis. SB cells were grown in the presence ofiztrnl nonrtu rif annh arrantn nlannn r%.r Asrithrlrtc ;1 UV VdiIUUa . 4ia agentL or i combination to.nenraiosdetermine the concentrations.i .U to examined across a range of concentrations from those that re- required pro- duced the net production of SB cells to zero (cytostatic) to those duce the saine degree of effect. Because for cancer chemo- that killed 90% of the cells after 72 hr (cytotoxic). Fig. 1 shows therapeutic agents the drug concentrations that are of most in- the isobolograms for the interaction ofeach pair ofdrugs at con- terest are those that produce cell killing, drug interactions were centrations producing cytostasis. The intercepts on the ordinate and abscissa indicate the cytostatic concentration of each drug 1.2- used alone. Ifthere were no interaction between the drugs and LA the agents were purely additive, then the data points for the 1.0- A combinations of two drugs causing cytostasis would fall on a 0.8- straight line connecting the intercepts. If the interaction were antagonistic, the line joining the intercepts would be convex. 0.6. In this case, the data points were found to describe a concave curve, which indicates synergy. For Ara-C in combination with 0.4- either dThd or HU, synergy was also observed at drug concen- 0.2- trations reducing the number of viable cells to as little as one 1/10th the number at the start of the culture (cytotoxic). The degree ofsynergy, as reflected by the degree ofconcavity ofthe 0.1 0.2 0.3 0.4 0.5 isobologram, was greater at cytotoxic drug concentrations than Ara-C ,uM at cytostatic concentrations (Fig. 2). 60 The isobologram for the cytostatic triple combination ofAra- 50 B C, dThd, and HU is shown in Fig. 3. On this plot, complete absence of any interaction would be reflected by a plane inter- 40 secting each of the three axes at the intercepts. Antagonism 30 20 0 0 10 dThd 0.1 0.2 0.3 0.4 0.5 Ara-C, AM 1.2 4 1.0 C 0.8 - I -0"0 0.6- "0 0.4- 0.2 - 20 40 60 80 HU, AuM Ara-C FIG.
Load more

Recommended publications
  • 2'-Deoxyguanosine Toxicity for B and Mature T Lymphoid Cell Lines Is Mediated by Guanine Ribonucleotide Accumulation
    2'-deoxyguanosine toxicity for B and mature T lymphoid cell lines is mediated by guanine ribonucleotide accumulation. Y Sidi, B S Mitchell J Clin Invest. 1984;74(5):1640-1648. https://doi.org/10.1172/JCI111580. Research Article Inherited deficiency of the enzyme purine nucleoside phosphorylase (PNP) results in selective and severe T lymphocyte depletion which is mediated by its substrate, 2'-deoxyguanosine. This observation provides a rationale for the use of PNP inhibitors as selective T cell immunosuppressive agents. We have studied the relative effects of the PNP inhibitor 8- aminoguanosine on the metabolism and growth of lymphoid cell lines of T and B cell origin. We have found that 2'- deoxyguanosine toxicity for T lymphoblasts is markedly potentiated by 8-aminoguanosine and is mediated by the accumulation of deoxyguanosine triphosphate. In contrast, the growth of T4+ mature T cell lines and B lymphoblast cell lines is inhibited by somewhat higher concentrations of 2'-deoxyguanosine (ID50 20 and 18 microM, respectively) in the presence of 8-aminoguanosine without an increase in deoxyguanosine triphosphate levels. Cytotoxicity correlates instead with a three- to fivefold increase in guanosine triphosphate (GTP) levels after 24 h. Accumulation of GTP and growth inhibition also result from exposure to guanosine, but not to guanine at equimolar concentrations. B lymphoblasts which are deficient in the purine salvage enzyme hypoxanthine guanine phosphoribosyltransferase are completely resistant to 2'-deoxyguanosine or guanosine concentrations up to 800 microM and do not demonstrate an increase in GTP levels. Growth inhibition and GTP accumulation are prevented by hypoxanthine or adenine, but not by 2'-deoxycytidine.
    [Show full text]
  • High-Throughput Profiling of Nucleotides and Nucleotide Sugars
    Journal of Biotechnology 229 (2016) 3–12 Contents lists available at ScienceDirect Journal of Biotechnology j ournal homepage: www.elsevier.com/locate/jbiotec High-throughput profiling of nucleotides and nucleotide sugars to evaluate their impact on antibody N-glycosylation a,1 b,1 a c Thomas K. Villiger , Robert F. Steinhoff , Marija Ivarsson , Thomas Solacroup , c c b b b Matthieu Stettler , Hervé Broly , Jasmin Krismer , Martin Pabst , Renato Zenobi , a a,d,∗ Massimo Morbidelli , Miroslav Soos a Institute for Chemical and Bioengineering, Department of Chemistry and Applied Biosciences, ETH Zurich, CH- 8093 Zurich, Switzerland b Laboratory of Organic Chemistry, Department of Chemistry and Applied Biosciences, ETH Zurich, CH-8093 Zurich, Switzerland c Merck Serono SA, Corsier-sur-Vevey, Biotech Process Sciences, ZI B, CH-1809 Fenil-sur-Corsier, Switzerland d Department of Chemical Engineering, University of Chemistry and Technology, Technicka 5, 166 28 Prague, Czech Republic a r t i c l e i n f o a b s t r a c t Article history: Recent advances in miniaturized cell culture systems have facilitated the screening of media additives on Received 5 October 2015 productivity and protein quality attributes of mammalian cell cultures. However, intracellular compo- Received in revised form 16 April 2016 nents are not routinely measured due to the limited throughput of available analytical techniques. In this Accepted 20 April 2016 work, time profiling of intracellular nucleotides and nucleotide sugars of CHO-S cell fed-batch processes Available online 27 April 2016 in a micro-scale bioreactor system was carried out using a recently developed high-throughput method based on matrix-assisted laser desorption/ionization (MALDI) time-of-flight mass spectrometry (TOF- Keywords: MS).
    [Show full text]
  • Consequences of Methotrexate Inhibition of Purine Biosynthesis in L5178Y Cells'
    [CANCER RESEARCH 35, 1427-1432,June 1975] Consequences of Methotrexate Inhibition of Purine Biosynthesis in L5178Y Cells' William M. Hryniuk2 Larry W. Brox,3J. Frank Henderson, and Taiki Tamaoki DepartmentofMedicine, University ofManitoba,and TheManitoba Institute ofCellBiology, Winnipeg,Manitoba [W. M. H.J and CancerResearch Unit (McEachern Laboratory), and DepartmentofBiochemistry, University ofAlberta, Edmonton,Alberta T6G 2E1 [L. W. B.,J. F. H., T. T.J,Canada SUMMARY recently been shown that the cytotoxicity of methotrexate against cultured mouse lymphoma L5178Y cells is in part Addition of 1 @Mmethotrexate to cultures of L5178Y attributable to a “purineless―state(6, 7). Thus, hypoxan cells results in an initial inhibition ofthymidine, uridine, and thine partially prevented the methotrexate-induced inhibi leucine incorporation into acid-insoluble material followed, tion of thymidine, uridine, and leucine incorporation into after about 10 hr. by a partial recovery in the extent of macromolecules and also delayed the loss ofcell viability, as incorporation of these precursors. Acid-soluble adenosine measured by cloning experiments. These studies also triphosphate and guanosine triphosphate concentrations are showed that, during incubation of L5178Y cells with greatly reduced initially, but guanosine triphosphate con methotrexate in the absence of hypoxanthine, incorporation centrations appear to recover partially by 10 hr. Acid of thymidine into DNA was first inhibited but later partially soluble uridine triphosphate and cytidine
    [Show full text]
  • A Path Towards SARS-Cov-2 Attenuation: Metabolic Pressure on CTP Synthesis Rules the Virus Evolution
    bioRxiv preprint doi: https://doi.org/10.1101/2020.06.20.162933; this version posted June 21, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-ND 4.0 International license. 1 A path towards SARS-CoV-2 attenuation: metabolic pressure on CTP synthesis rules the virus evolution Zhihua Ou1,2, Christos Ouzounis3, Daxi Wang1,2, Wanying Sun1,2,4, Junhua Li1,2, Weijun Chen2,5*, Philippe Marlière6, Antoine Danchin7,8* 1. BGI-Shenzhen, Shenzhen 518083, China. 2. Shenzhen Key Laboratory of Unknown Pathogen Identification, BGI-Shenzhen, Shenzhen 518083, China. 3. Biological Computation and Process Laboratory, Centre for Research and Technology Hellas, Chemical Process and Energy Resources Institute, Thessalonica 57001, Greece 4. BGI Education Center, University of Chinese Academy of Sciences, Shenzhen, 518083, China. 5. BGI PathoGenesis Pharmaceutical Technology, BGI-Shenzhen, Shenzhen, China. 6. TESSSI, The European Syndicate of Synthetic Scientists and Industrialists, 81 rue Réaumur, 75002, Paris, France 7. Kodikos Labs, Institut Cochin, 24, rue du Faubourg Saint-Jacques Paris 75014, France. 8. School of Biomedical Sciences, Li KaShing Faculty of Medicine, Hong Kong University, 21 Sassoon Road, Pokfulam, Hong Kong. * To whom correspondence should be addressed Tel: +331 4441 2551; Fax: +331 4441 2559 E-mail: [email protected] Correspondence may also be addressed to [email protected] Keywords ABCE1; cytoophidia; innate immunity; Maxwell’s demon; Nsp1; phosphoribosyltransferase; queuine bioRxiv preprint doi: https://doi.org/10.1101/2020.06.20.162933; this version posted June 21, 2020.
    [Show full text]
  • Expression, Localization, and Kinetic Characterization of The
    Illinois State University ISU ReD: Research and eData Theses and Dissertations 6-5-2015 Expression, localization, and kinetic characterization of the phospholipid biosynthesis enzyme CTP: phosphocholine cytidylyltransferase from the protozoan parasite Leishmania major Justin Daniel Theodore Lange Illinois State University, [email protected] Follow this and additional works at: https://ir.library.illinoisstate.edu/etd Part of the Biochemistry Commons, Cell Biology Commons, and the Parasitology Commons Recommended Citation Lange, Justin Daniel Theodore, "Expression, localization, and kinetic characterization of the phospholipid biosynthesis enzyme CTP: phosphocholine cytidylyltransferase from the protozoan parasite Leishmania major" (2015). Theses and Dissertations. 451. https://ir.library.illinoisstate.edu/etd/451 This Thesis is brought to you for free and open access by ISU ReD: Research and eData. It has been accepted for inclusion in Theses and Dissertations by an authorized administrator of ISU ReD: Research and eData. For more information, please contact [email protected]. EXPRESSION, LOCALIZATION, AND KINETIC CHARACTERIZATION OF THE PHOSPHOLIPID BIOSYNTHESIS ENZYME CTP: PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE FROM THE PROTOZOAN PARASITE LEISHMANIA MAJOR Justin D.T. Lange 99 Pages The eukaryotic parasite Leishmania is the causative agent of the disease leishmaniasis. L. major is the most common of 21 species that causes visceral leishmaniasis in humans, and 30 that cause the same disease in other mammals. Visceral leishmaniasis causes fever, weight loss, and over a short amount of time, multiple organ failure, and has a 100% mortality rate within 2 years. This makes it the second largest parasitic killer in the world behind malaria. Over 90% of the world’s cases of visceral leishmaniasis have been reported in underdeveloped countries of India, Bangladesh, Nepal, Sudan, Ethiopia and Brazil, with 500,000 new cases being diagnosed worldwide each year.
    [Show full text]
  • 190323111.Pdf
    Characterization of polymers of nucleotide biosynthetic enzymes By Sajitha Anthony April, 2017 A dissertation presented to the faculty of Drexel University College of Medicine in partial fulfillment for the requirements for the degree of Doctor of Philosophy in Molecular and Cellular Biology and Genetics i ii ACKNOWLEDGEMENTS First and foremost, I would like to thank my mentor Dr. Jeffrey Peterson for all of his support and guidance throughout the five years that I have been in his lab. He has truly inspired me with his tremendous enthusiasm for science and his constant encouragement. He has changed, for the better, the way I approach and see science. I could not have asked for a better mentor. Secondly, I would like to thank my committee members for all of their great ideas and their never-ending support. I thank them for answering all of my questions so patiently and always listening to what I had to say. After every meeting I’ve had with them, I always felt encouraged and confident. I would also like to thank my collaborators over at the University of Washington—Justin Kollman, Anika Burrell, and Matthew Johnson. It has been such a pleasure working with them. The journey of discovery that we took together has been very exciting. This was my first collaboration, and they have made it such a memorable and positive experience. iii I would like to thank my lab members, in particular Alex for being an awesome cubemate, colleague, and friend. He has been the sounding board for so many of my project’s ideas over the years and has given such knowledgeable input.
    [Show full text]
  • Synthesis of Nucleoside Polyphosphates and Their Conjugates
    Synthesis of Nucleoside Polyphosphates and their Conjugates by Samy Mohamady Mohamady A thesis presented to the University of Waterloo in fulfillment of the thesis requirement for the degree of Doctor of Philosophy in Chemistry Waterloo, Ontario, Canada, 2013 ©Samy Mohamady Mohamady 2013 AUTHOR’S DECLARATION I hereby declare that I am the sole author of this thesis. This is a true copy of the thesis, including any required final revisions, as accepted by my examiners. I understand that my thesis may be made electronically available to the public. ii Abstract Nucleoside polyphosphates and their conjugates, such as nucleoside triphosphates, nucleoside tetraphosphates, sugar nucleotides, dinucleoside pyro- and higher order polyphosphates, 2’,3’-cyclic nucleoside monophosphates, and 2´-deoxynucleoside-5´- tetraphosphates in which a fluorescent label is attached to the terminal phosphate have many biological roles and have been developed into drugs. However, their synthesis remains a challenge. Several novel and efficient approaches to the synthesis of nucleoside polyphosphates and their conjugates were developed. In the first approach dinucleoside polyphosphates (NpnN’s where n = 2-4) are prepared via in situ trifluoroacetate protection and imidazolium activation of nucleoside 5’-monophosphates. This methodology was also used to prepare a substrate- intermediate analog of the reaction catalyzed by cytidine triphosphate synthase (CTPS) a recognized target for the development of antineoplastic, antiviral and antiprotozoal agents. The second approach uses sulfonylimidazolium salts as key reagents for generating highly reactive nucleotide donors. The procedure is rapid, produces a wide variety of nucleoside polyphosphates and their conjugates in high yield, does not require protection and subsequent deprotection of the nucleotide donors or acceptors and can be used to activate nucleoside mono-, di-, and triphosphates and a wide variety of acceptors.
    [Show full text]
  • Nucleotide and Nucleotide Sugar Analysis in Cell Extracts By
    732 CHIMIA 2016, 70, No. 10 Columns doi:10.2533/chimia.2016.732 Chimia 70 (2016) 732–735 © Swiss Chemical Society FH Universities of Applied Sciences HES Fachhochschulen – Hautes Ecoles Spécialisées Nucleotide and Nucleotide Sugar Analysis in Cell biopharmaceutical industry interest has arisen to investigate and Extracts by Capillary Electrophoresis understand the regulation and biosynthesis of the glycosylation process in order to obtain optimal cultivation conditions. The Blanka Bucsella, Antoine Fornage, Catherine Le Denmat, mammalian glycosylation process (the glycan synthesis and the and Franka Kálmán* glycan attachment to the protein backbone) takes place in the *Correspondence: Prof. Dr. F. Kálmán, E-mail: [email protected], HES-SO endoplasmic reticulum (ER) and the Golgi apparatus with sugar Valais, University of Applied Sciences, Sion, Wallis, Institute of Life Technologies, nucleotides (activated monosaccharaides) as precursors.[5] These Route du Rawyl 47, CH-1950 Sion 2 sugar nucleotides are uridine diphosphate N-acetylglucosamine (UDP-GlcNAc), uridine diphosphate glucose (UDP-Glc), uridine Abstract: In biotechnological processes the intracellular level diphosphate N-acetylgalactosamine (UDP-GalNAc), uridine of nucleotides and nucleotide sugars have a direct impact diphosphate galactose (UDP-Gal), guanosine diphosphate on the post-translational modification (glycosylation) of the mannose (GDP-Man), guanosine diphosphate fucose (GDP- therapeutic protein products and on the exopolysaccharide Fuc), cytidine monophosphate N-acetylneuraminic acid (CMP- pattern of the cells. Thus, they are precursors and also key Neu5Ac), uridine diphosphate glucoronic acid (UDP-GlcA) components in the production of glycoproteins and glycolipids. and cytidine monophosphate N-glycolylneuraminic acid All four nucleotides (at different phosphorylation stages) and (CMPNeu5Gc). In the biosynthesis of the sugar nucleotides the their natural sugar derivatives coexist in biological samples.
    [Show full text]
  • 2425.Full.Pdf
    [CANCER RESEARCH 33. 2425 2430, October 1973) Furine Nucleotide Metabolism and Nucleotide Pool Sizes in Synchronized Lymphoma L5178Y Cells1 Floyd F. Snyder, J. Frank Henderson, S. C. Kim, A. R. P. Peterson, and L. W. Brox University of Alberta Cancer Research Unit (McEachern Laboratory) and Department of Biochemistry. University oíAlberta, Edmonton, Alberta. T6G 2EÌ,Canada SUMMARY MATERIALS AND METHODS Mouse lymphoma L5178Y cells in culture were syn Cell Cultures. Mouse lymphoma LSI78Y cells were chronized by exposure to thymidine and Colcemid. At four routinely grown in suspension cultures with Fischer's me times during the cell cycle, various aspects of purine metab dium (Grand Island Biological Co., Grand Island, N. Y.) olism were examined with the use of radioactive purine supplemented with 10% horse serum, streptomycin (100 bases. In all experiments the uptake and conversion of bases Mg/ml), and penicillin (100 units/ml) (17). Cell numbers to nucleotides was rate limiting for ribonucleoside triphos- were determined with Coulter Model F or B electronic phate synthesis. Cell cycle variations in the apparent en particle counters. The cells were synchronized by 5 hr of zyme activities of the purine phosphoribosyltransferases, exposure to 2 mM thymidine followed by 5 hr of exposure adenosine monophosphate deaminase and guanosine mono- to 0.02 /ig Colcemid per ml (Grand Island Biological Co.). phosphate reducíase,were observed. Purine and pyrimidine This procedure is similar to that described by Doida and nucleotide pool sizes were determined by high-pressure Okada (9). After resuspension in fresh medium, between liquid chromatography. After correction for increases in 70 and 80% of the cells present underwent synchronous cell volume, it was observed that nicotinamide adenine di- division (Chart 1).
    [Show full text]
  • Supplemental Information Table S1, Related to Figure 1. Summary Characteristics of the Leigh Syndrome Patient Derived Fibroblast
    Supplemental Information Table S1, Related to Figure 1. Summary characteristics of the Leigh syndrome patient derived fibroblast cell lines including the patient phenotype at diagnosis, the mutations identified, and published literature using the cell line. Table S2, Related to Figure 4. Day 10 LS derived neutralized embryoid bodies relative metabolite abundance for metabolites used in pathway analysis. LC-MS measured metabolite peak areas were normalized to the total ion count (TIC) by sample and fold change was determined by dividing each LS TIC normalized peak area by the control TIC normalized peak area for each metabolite. Metabolites were identified and filtered for pathway analysis using a threshold fold change (FC >5 and <0.4). Fold change values shown are averages for 2 independent runs with ~150 neuralized EBs per run. Table S3, Related to Figure 4. Summary of the metabolic pathways analysis for metabolites enriched in day 10 LS derived neuralized embryoid bodies. Statistical p values from enrichment analysis are adjusted for multiple hypothesis testing. Total: total number of compounds in the pathway. Hits: matched number from the uploaded data. Raw p: original p value calculated from the enrichment analysis. Holm p: p value adjusted by Holm-Bonferroni method. FDR p: adjusted p value using False Discovery Rate. Impact: pathway impact value calculated from pathway topology analysis. Figure S1, Related to Figure 2. Characterization of Leigh syndrome iPSCs. A. Schematic representation of the fibroblast reprogramming protocol. B-C. Pluripotency characterization of the LS iPSCs. Samples were analyzed against samples in a reference data set (The International Stem Cell Initiative, 2018) (B).
    [Show full text]
  • Regulation of Human Cytidine Triphosphate Synthetase 1 by Phosphorylation and Interacting Proteins
    REGULATION OF HUMAN CYTIDINE TRIPHOSPHATE SYNTHETASE 1 BY PHOSPHORYLATION AND INTERACTING PROTEINS Matthew James Higgins A dissertation submitted to the faculty of the University of North Carolina at Chapel Hill in partial fulfillment of the r equirements for the degree of Doctor of Philosophy in the Department of Pharmacology Chapel Hill 2007 Approved by Professor Lee M Graves Professor Beverly Mitchell Professor Mike Schaller Professor Chris Mack Professor Jeffrey MacDonald ©2007 Matthew James Higgins ALL RIGHTS RESERVED ii ABSTRACT MATTHEW JAMES HIGGINS: Regulation of Human Cytidine Triphosphate Synthetase 1 by Phosphorylation and Interacting Proteins (Under the direction of Dr. Lee M Grave s) CTP is essential for the synthesis of phospholipids, DNA/RNA and the sialylation of proteins. Of the two pathways known to synthesize CTP ( de novo and salvage), the de novo synthesis pathway is thought to be the key regulator of CTP pool size in mamma lian cells. CTPS is the rate -limiting enzyme in the de novo synthesis of CTP. CTPS catalyzes the amination of UTP to form CTP using glutamine as the amine donor and GTP as an allosteric activator. ATP is hydrolyzed in the process and CTP is a feedback i nhibitor. In S. cerevisiae CTP synthetase (CTPS) is regulated by phosphorylation by PKA and PKC. The goals of this study were to investigate phosphorylation regulation of mammalian CTPS1 and elucidate CTPS1 interacting proteins. PKA or PKC were found no t to be involved in the phosphorylation of CTPS1 in intact HEK 293 cells. However, endogenous human CTPS1 was phosphorylated under low -serum conditions in a GSK3 -dependent manner.
    [Show full text]
  • 19740014600.Pdf
    NASA-CB-138379) CHANGES IN SULFHYDRYL - N74-22713 GROUPS.OF HONEYBEE GLYCERALDEYDE PHOSPHATE DEHYDROGENASE ASSOCIATED WITH GENERATION OF THE (Hassachusetts Univ.) Unclas 42 p HC $5.25 CSCL 06A G3/04 16458 University of Massachusetts Changes In Sulfhydryl Groups Of Honeybee Glyceraldehyde Phosphate Dehydrogenase Associated With Generation Of The Intermediate Plateau In Its Saturation Kineticst tDepartment of Biochemistry University of Massachusetts Amherst, Massachusetts 01002 Supported by grants from NASA (NGL 22-010-029) and the Herman Frasch Foundation W. G. Gelb, J. F. Brandts and J. H. Nordin Running Title: Sulfhydryl Groups and Intermediate Plateau in GPDH. JUL9 1973 PRIVILEGED BIOCHEMISTRY COMMUNICATION ABSTRACT Experiments with honeybee (Apis mellifera)and rabbit muscle GPDH were conducted to obtain information at the chemical level regarding anomolous saturation kinetics of the honeybee enzyme. Results demonstrate that the enzyme's sulfhydryl groups are implicated in the process. Measured by DTNB titration, native honeybee GPDH has one less active SH than the native rabbit muscle enzyme and displays changes in overall sulfhydryl reactivity after preincubation with G-3-P or G-3-P plus NAD + . The total DTNB reactive sulfhydryls of rabbit muscle GPDH are not changed by preincubation with NAD or G-3-P; honeybee GPDH, under certain conditions of preincubation with these ligands, shows a decrease of two total DTNB reactive SH groups. This difference has been confirmed by an independent experiment in which the two enzymes were carboxymethylated 14 with C-bromoacetic acid. The loss of SH groups in honeybee GPDH is not a result of its acylation by G-3-P. After generation of the stable form of the honeybee.enzyme with G-3-P plus NAD + it is possible to regenerate the anomolous kinetic curve by ti:eatment of the enzyme with dithiothreitol.
    [Show full text]